搜索临床试验以:AT-007
总计4174个结果
-
MedImmune LLC完全的
-
PrimeVax Immuno-Oncology Inc.Walter Reed Army Institute of Research (WRAIR)尚未招聘
-
Nanjing Leads Biolabs Co.,Ltd招聘中
-
Tasly Pharmaceutical Group Co., LtdSutro Biopharma, Inc.招聘中
-
National Cancer Institute (NCI)完全的不可切除的恶性实体肿瘤 | 转移性恶性实体瘤 | 复发性乳腺癌 | 转移性三阴性乳腺癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类耐药卵巢癌 | 复发性原发性腹膜高级别浆液性腺癌 | 复发性三阴性乳腺癌 | 转移性高级别输卵管浆液性腺癌 | 转移性原发性腹膜浆液性腺癌 | 复发性高级别输卵管浆液性腺癌 | 复发性高级别卵巢浆液性腺癌 | 难治性输卵管浆液性腺癌 | 难治性卵巢浆液性腺癌 | 难治性原发性腹膜浆液性腺癌 | 难治性三阴性乳腺癌 | 不可切除的高级别输卵管浆液性腺癌 | 不可切除的原发性腹膜浆液性腺癌美国
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
Shandong New Time Pharmaceutical Co., LTD尚未招聘RR DLBCL; PD-1; CD20
-
University Medical Center GroningenMendus招聘中
-
Sutro Biopharma, Inc.完全的滤泡性淋巴瘤 | B细胞淋巴瘤 | 多发性骨髓瘤 | 套细胞淋巴瘤 | 非霍奇金淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 惰性淋巴瘤 | B细胞--肿瘤美国
-
Carnegie Mellon UniversityJohns Hopkins Bloomberg School of Public Health; University of Michigan; University of Oxford; Voluntary... 和其他合作者邀请报名
-
Anthera Pharmaceuticals完全的
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology Consortium; Curis, Inc.; Cannonball Kids' Cancer Foundation主动,不招人
-
Entos Pharmaceuticals Inc.Q2 Solutions; Calian CRO; PCI Pharma Services尚未招聘
-
University of California, San DiegoCalifornia Institute for Regenerative Medicine (CIRM); n-Lorem Foundation主动,不招人
-
National Institutes of Health Clinical Center (CC)完全的
-
Azura OphthalmicsThe University of New South Wales完全的
-
MitoImmune Therapeutics主动,不招人
-
International Partnership for Microbicides, Inc.完全的
-
ABX advanced biochemical compounds GmbH尚未招聘前列腺癌 | 新诊断的前列腺癌
-
BioNova Pharmaceuticals (Shanghai) LTD.终止
-
Icahn School of Medicine at Mount Sinai未知
-
Heron Therapeutics完全的